- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04694066
Qigong for Pre-frail and Frail Older Cancer Survivors
Qigong for Pre-frail and Frail Older Cancer Survivors: A Pilot Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Frailty is an emerging concept in geriatric research and practice. It is defined as a state of increased vulnerability to adverse outcomes including death. A cohort study has found that respondents with cancer were significantly more frail compared to those without cancer. A plausible explanation is both cancer itself and the therapies used to treat it add additional stressors that challenge a patient's physiologic reserve. A systematic review has revealed a high prevalence of frailty and pre-frailty in older cancer patients, with the median estimates of 42% and 43%, respectively. Cancer treatment can hasten survivors' aging process and increase their risk of developing frailty, thus placing cancer survivors at heightened risk of such poor health outcomes as falls, fractures, and disability. This calls for effective interventions that would improve frailty in older cancer survivors.
Qigong, a type of mind-body intervention, is particularly suitable for older adults, as it is implemented without aerobic and musculoskeletal strain. This equipment-free form of exercise is ideal for settings with limited resources, as well as for the frail elderly, because it can be performed at home at any time, reducing such barriers as weather, transportation, and cost. Meta-analysis suggests that Baduanjin is beneficial in the general population in terms of improved quality of life, balance, handgrip strength, and trunk flexibility. To our knowledge, there is no evidence on qigong's effects for improving well-being of pre-frail and frail older cancer survivors. Our aim is therefore to conduct a pilot study for testing out the feasibility and acceptability of a qigong intervention to the elderly cancer survivors.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- Pamela Youde Nethersole Eastern Hospital
-
Hong Kong, Hong Kong, 000
- Queen Mary Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged ≥65
- diagnosed with stage I-III non-metastatic cancer
- completed primary treatment with curative intent (surgery, chemotherapy, and/or radiation therapy) 6 months to 5 years prior to baseline assessments with no recurrence or occurrence of additional cancers
- classified as pre-frail or frail based on Fried frailty criteria
- can communicate in Cantonese or Putonghua
- written informed consent
Exclusion Criteria:
- regular qigong training or other mind body intervention (once or more per week) within the previous 6 months
- medical conditions affecting mobility, predisposing to falls, or precluding qigong practice (e.g., neurological disease, musculoskeletal disorder, recent myocardial infarction, breathing difficulties requiring oxygen)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Qigong
The entire intervention will last 16 weeks, including 1-hour supervised training sessions twice a week during weeks 1 to 8 (training; 16 hours), and 1-hour supervised weekly follow-up sessions during weeks 9 to 16 (followup; 8 hours).
The sessions will be supervised by an experienced qigong master.
|
Qigong Baduanjin, comprising eight standardized movements, will be adopted in the study.
It is practiced as a combination of body movements, breath control, and mindful meditation.
|
|
Active Comparator: Light flexibility exercise
The control group will practice light flexibility exercise only, with the same duration and frequency of supervised sessions identical to the qigong sessions.
The supervised sessions will be conducted by a certified exercise trainer.
|
The supervised sessions will include seated and standing stretches that target upper (neck, arms, upper back, shoulders, and chest) and lower body (quadriceps, hamstrings, calves, and hips), as well as trunk rotations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility: Study completion rate
Time Frame: 16 weeks
|
The proportion of participants who completed the data collection among those randomized will be recorded at each time point.
|
16 weeks
|
|
Feasibility: Attendance rate
Time Frame: 16 weeks
|
Participants' attendance to the supervised sessions will be recorded at each time point.
|
16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in frailty status
Time Frame: study entry, 8 weeks, 16 weeks
|
Participants' frailty status will be assessed using the Fried frailty criteria, which consists of 5 criteria: slowness , weakness , unintentional weight loss , exhaustion and low activity.
|
study entry, 8 weeks, 16 weeks
|
|
Change in Short Physical Performance Battery scores
Time Frame: study entry, 8 weeks, 16 weeks
|
Short Physical Performance Battery is an objective assessment tool used to measure the physical performance of participants in three functional tasks.
|
study entry, 8 weeks, 16 weeks
|
|
Change in Short-Form Geriatric Depression Scale scores
Time Frame: study entry, 8 weeks, 16 weeks
|
The Short-Form Geriatric Depression Scale (15 items) will be used to measure psychological well-being.
Scores range from 0 to 15, with higher scores representing more severe depressive symptoms.
|
study entry, 8 weeks, 16 weeks
|
|
Change in European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire-C30 scores
Time Frame: study entry, 8 weeks, 16 weeks
|
European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire-C30 (30 items) will be used to assess health-related quality of life specifically in cancer patients.
The questionnaire is composed of five functional scales, three symptom scales, a global health status / QoL scale, and six single items.
scale.
Scores of all subscales and single-item measures range from 0 to 100.
Higher scores for functional scales represent higher level of functioning, global health status/quality of life, but higher scores for a symptom scale / item represent a higher level of symptom severity.
|
study entry, 8 weeks, 16 weeks
|
|
Change in Modified Barthel Index scores
Time Frame: study entry, 8 weeks, 16 weeks
|
The Modified Barthel Index will be used to measure participants' performance in activities of daily living such as eating, personal hygiene, and bathing, rated on an arbitrary 2- to 4-point scale depending on the amount of assistance needed.
Scores range from 0 (an inability to perform) to 15 (total independence).
|
study entry, 8 weeks, 16 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Denise Cheung, The University of Hong Kong
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HKUCTR-2708
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
Morehouse School of MedicineRecruiting
Clinical Trials on Qigong
-
Florida International UniversityArizona State UniversityCompletedMental Health | Physical HealthUnited States
-
Tri-Service General HospitalCompletedCognitive Dysfunction | Exercise Training | Cognitive Decline | Cognitive Aging | Grip | Physical Endurance
-
Ching-I ChangTaipei Hospital, TaiwanCompletedQuality of Life | Breast Cancer | Intraoperative AwarenessTaiwan
-
Nova Scotia Health AuthorityCompletedChronic Pain
-
Radboud University Medical CenterUniversitas TarumanagaraCompletedDepressive Symptoms | Well-beingIndonesia
-
Akdeniz UniversityCompletedQuality of Life | Postoperative Pain | Muscle Weakness | Pain, Shoulder | Respiratory Function Loss | Joint AdhesionTurkey
-
University of HoustonBrigham and Women's Hospital; Texas Woman's UniversityActive, not recruitingQuality of Life | Physical Function | Caregiver DistressUnited States
-
Eman Mohamed othmanNot yet recruiting
-
Lund UniversityThe Swedish Institute for Health Sciences; Ekhaga foundation; Greta and Johan...CompletedLumbar Disc Herniation | Lumbago | Chronic Low Back Pain | Lumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Disc Degeneration | Chronic Sciatica | Persistent Postoperative PainSweden
-
Dartmouth-Hitchcock Medical CenterCompletedFalls, Balance Self-confidenceUnited States